Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaJan A. Burger, Thomas J. Kipps, Osnat Bairey et al.|New England Journal of Medicine|2015Cited by 1.6k
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic LeukemiaJohn F. Seymour, Arnon P. Kater, Thomas J. Kipps et al.|New England Journal of Medicine|2018Cited by 907
International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendationsAdam S. Kittai, Paolo Ghia, Monia Marchetti et al.|Blood|2025Cited by 14